Pricing Log in Create free account

Cellectar Biosciences, Inc. (CLRB) vs Tempest Therapeutics, Inc. (TPST)

Cellectar Biosciences, Inc. and Tempest Therapeutics, Inc. are both Biotechnology companies. Cellectar Biosciences, Inc. and Tempest Therapeutics, Inc. are of similar size ($11.2M and $10.7M). Across the 7 metrics below, Cellectar Biosciences, Inc. leads on 6 and Tempest Therapeutics, Inc. on 1.

Valuation

Metric CLRB TPST Biotechnology median
P/E n/m n/m 8.50
P/S n/m 29.13 9.71
P/B 0.47 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.84 n/m 0.64
EV/Sales n/m 33.65 9.21
Earnings yield (336.84%) (690.32%) (33.15%)
Free cash flow yield (140.17%) (224.23%) (25.50%)

Profitability

Metric CLRB TPST Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (125.99%) (931.14%) (56.36%)
Return on assets (88.70%) (237.25%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLRB TPST Biotechnology median
Revenue growth (TTM) — (52.98%) 6.02%
EPS growth (last fiscal year) 80.14% 67.55% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLRB TPST Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.66 0.38 4.72
Net debt to EBITDA 0.58 0.29 0.96

Dividend

Metric CLRB TPST Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CLRB TPST Biotechnology median
Market cap 11.24m 10.73m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack